Literature DB >> 11404249

Dopamine regulates Na-K-ATPase in alveolar epithelial cells via MAPK-ERK-dependent mechanisms.

C Guerrero1, E Lecuona, L Pesce, K M Ridge, J I Sznajder.   

Abstract

Dopamine (DA) increases lung edema clearance by regulating vectorial Na+ transport and Na-K-ATPase in the pulmonary epithelium. We studied the role of the mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase (ERK) pathway in the DA regulation of Na-K-ATPase in alveolar epithelial cells (AEC). Incubation of AEC with DA resulted in a rapid stimulation of ERK activity via dopaminergic type 2 receptors. Analysis of total RNA and protein showed a 1.5-fold increase in the Na-K-ATPase beta1-subunit mRNA levels and up to a fivefold increase in beta1-subunit protein abundance after DA stimulation, which was blocked by the MAPK kinase (MEK) inhibitors PD-98059 and U-0126. Also, the DA-ERK pathway stimulated the synthesis of a green fluorescent protein reporter gene driven by the beta1-subunit promoter, which indicates that DA regulates the Na-K-ATPase beta1-subunit at the transcriptional level. The DA-mediated increase in beta1-subunit mRNA protein resulted in an increase in functional Na pumps in the basolateral membranes of alveolar type II cells. These results suggest that the MAPK-ERK pathway is an important mechanism in the regulation of Na-K-ATPase by DA in the alveolar epithelium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404249     DOI: 10.1152/ajplung.2001.281.1.L79

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  23 in total

1.  Bystander effect on cell growth stimulation in neoplastic HSGc cells induced by heavy-ion irradiation.

Authors:  Chunlin Shao; Mizuho Aoki; Yoshiya Furusawa
Journal:  Radiat Environ Biophys       Date:  2003-08-15       Impact factor: 1.925

2.  Dopamine inhibits pulmonary edema through the VEGF-VEGFR2 axis in a murine model of acute lung injury.

Authors:  Pawan K Vohra; Luke H Hoeppner; Gunisha Sagar; Shamit K Dutta; Sanjay Misra; Rolf D Hubmayr; Debabrata Mukhopadhyay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

Review 3.  The dopamine paradox in lung and kidney epithelia: sharing the same target but operating different signaling networks.

Authors:  Alejandro M Bertorello; Jacob I Sznajder
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11       Impact factor: 6.914

Review 4.  Alveolar epithelial ion and fluid transport: recent progress.

Authors:  Hans G Folkesson; Michael A Matthay
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-02       Impact factor: 6.914

Review 5.  Renal dopaminergic system: Pathophysiological implications and clinical perspectives.

Authors:  Marcelo Roberto Choi; Nicolás Martín Kouyoumdzian; Natalia Lucía Rukavina Mikusic; María Cecilia Kravetz; María Inés Rosón; Martín Rodríguez Fermepin; Belisario Enrique Fernández
Journal:  World J Nephrol       Date:  2015-05-06

Review 6.  Novel regulators of endothelial barrier function.

Authors:  Dolly Mehta; Krishnan Ravindran; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-07       Impact factor: 5.464

7.  Pulmonary Oedema-Therapeutic Targets.

Authors:  Ovidiu Chioncel; Sean P Collins; Andrew P Ambrosy; Mihai Gheorghiade; Gerasimos Filippatos
Journal:  Card Fail Rev       Date:  2015-04

8.  Dopamine D2-like receptor-mediated opening of K+ channels in opossum kidney cells.

Authors:  Pedro Gomes; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 9.  Ubiquitin-proteasome signaling in lung injury.

Authors:  Natalia D Magnani; Laura A Dada; Jacob I Sznajder
Journal:  Transl Res       Date:  2018-04-23       Impact factor: 7.012

10.  Activation of mitogen-activated protein kinase (mitogen-activated protein kinase/extracellular signal-regulated kinase) cascade by aldosterone.

Authors:  Eunan Hendron; James D Stockand
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.